Synthetic oxygen carriers in cardiac tissue engineering.

Tissue engineering: current strategies and future directions. Chonnam Med J (2011) 0.96

A modular approach to cardiac tissue engineering. Tissue Eng Part A (2010) 0.96

The role of tissue engineering and biomaterials in cardiac regenerative medicine. Can J Cardiol (2014) 0.78

Downregulation of metabolic activity increases cell survival under hypoxic conditions: potential applications for tissue engineering. Tissue Eng Part A (2014) 0.76

Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13

Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19

Stem cell-based tissue engineering with silk biomaterials. Biomaterials (2006) 2.88

The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79

Cell differentiation by mechanical stress. FASEB J (2001) 2.56

Engineering complex tissues. Tissue Eng (2006) 2.53

Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48

Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42

Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A (2009) 2.37

Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26

Silk implants for the healing of critical size bone defects. Bone (2005) 2.22

Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14

Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A (2011) 2.14

Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12

Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01

Electrical stimulation systems for cardiac tissue engineering. Nat Protoc (2009) 1.97

A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A (2012) 1.95

Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials (2005) 1.94

Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94

Influence of substrate stiffness on the phenotype of heart cells. Biotechnol Bioeng (2010) 1.82

High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng (2003) 1.77

Decellularization of human and porcine lung tissues for pulmonary tissue engineering. Ann Thorac Surg (2013) 1.76

Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release (2008) 1.72

Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials (2007) 1.72

Assembly of complex cell microenvironments using geometrically docked hydrogel shapes. Proc Natl Acad Sci U S A (2013) 1.70

Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A (2008) 1.70

Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68

Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66

Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol (2004) 1.65

Cardiac tissue engineering using perfusion bioreactor systems. Nat Protoc (2008) 1.65

Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol Bioeng (2004) 1.64

Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A (2008) 1.63

Silk fibroin microtubes for blood vessel engineering. Biomaterials (2007) 1.61

Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56

Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance. Curr Stem Cell Res Ther (2008) 1.53

Micro-bioreactor array for controlling cellular microenvironments. Lab Chip (2007) 1.52

Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species. Exp Cell Res (2009) 1.49

Tissue engineering by self-assembly and bio-printing of living cells. Biofabrication (2010) 1.48

Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng (2005) 1.48

Engineering bone tissue from human embryonic stem cells. Proc Natl Acad Sci U S A (2012) 1.47

Microfluidic patterning for fabrication of contractile cardiac organoids. Biomed Microdevices (2007) 1.46

Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng (2002) 1.46

Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45

The effect of actin disrupting agents on contact guidance of human embryonic stem cells. Biomaterials (2007) 1.45

Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors. Biomaterials (2006) 1.43

Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration. J Am Coll Cardiol (2012) 1.42

Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors. J Cardiovasc Transl Res (2011) 1.41

Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng (2006) 1.41

Engineering bone tissue substitutes from human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2013) 1.38

Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog (2009) 1.36

Tissue engineering by self-assembly of cells printed into topologically defined structures. Tissue Eng Part A (2008) 1.35

Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater (2008) 1.34

Tissue engineering and developmental biology: going biomimetic. Tissue Eng (2006) 1.34

Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum (2002) 1.31

Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials (2009) 1.31

Biomimetic approach to tissue engineering. Semin Cell Dev Biol (2008) 1.30

Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci U S A (2013) 1.29

Effect of scaffold design on bone morphology in vitro. Tissue Eng (2006) 1.28

Optimizing the medium perfusion rate in bone tissue engineering bioreactors. Biotechnol Bioeng (2010) 1.28

Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials (2011) 1.28

Micropatterned mammalian cells exhibit phenotype-specific left-right asymmetry. Proc Natl Acad Sci U S A (2011) 1.26

Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev (2010) 1.25

Engineering custom-designed osteochondral tissue grafts. Trends Biotechnol (2008) 1.25

Gel spinning of silk tubes for tissue engineering. Biomaterials (2008) 1.24

Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng Part A (2010) 1.24

Osteogenic differentiation of human bone marrow stromal cells on partially demineralized bone scaffolds in vitro. Tissue Eng (2004) 1.24

Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes. Biomaterials (2007) 1.23

Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng (2003) 1.23

Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials (2006) 1.22

Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci (2011) 1.22

Differential effects of growth factors on tissue-engineered cartilage. Tissue Eng (2002) 1.21

Biphasic electrical field stimulation aids in tissue engineering of multicell-type cardiac organoids. Tissue Eng Part A (2008) 1.20

Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of β-catenin signaling. Lab Chip (2010) 1.20

Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials (2010) 1.19

Development of silk-based scaffolds for tissue engineering of bone from human adipose-derived stem cells. Acta Biomater (2012) 1.18

Synovium-derived stem cell-based chondrogenesis. Differentiation (2008) 1.18

Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering. J Biomed Mater Res A (2009) 1.16

Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J (2002) 1.15

Nanofabrication and microfabrication of functional materials for tissue engineering. Tissue Eng (2007) 1.14

Peptide-mediated selective adhesion of smooth muscle and endothelial cells in microfluidic shear flow. Langmuir (2007) 1.13

Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant (2009) 1.13

Practical aspects of cardiac tissue engineering with electrical stimulation. Methods Mol Med (2007) 1.11

Effects of oxygen on engineered cardiac muscle. Biotechnol Bioeng (2002) 1.10

Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proc Natl Acad Sci U S A (2009) 1.10

Deterministic lateral displacement as a means to enrich large cells for tissue engineering. Anal Chem (2009) 1.09

Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A (2010) 1.09

Macrophages modulate the viability and growth of human mesenchymal stem cells. J Cell Biochem (2013) 1.09

Cell culture chips for simultaneous application of topographical and electrical cues enhance phenotype of cardiomyocytes. Lab Chip (2008) 1.08

Label-free enrichment of functional cardiomyocytes using microfluidic deterministic lateral flow displacement. PLoS One (2012) 1.08

Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications. Methods (2008) 1.07

In vitro model of vascularized bone: synergizing vascular development and osteogenesis. PLoS One (2011) 1.06

Ingrowth of human mesenchymal stem cells into porous silk particle reinforced silk composite scaffolds: An in vitro study. Acta Biomater (2010) 1.06

Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater (2007) 1.06